{
  "docId": "019de072-8046-72ee-8797-71c9ff7422eb",
  "docSlug": "98d74c454dfdfefd8fb9993ff5213b70",
  "documentTitle": "Hillevax | IPO Presentation Deck | 24 slides",
  "authorId": "hillevax",
  "authorName": "Hillevax",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2022-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 17,
  "pageCount": 24,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 15,
  "notes": "The slide highlights heterotypic protection across different NoV strains.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-8046-72ee-8797-71c9ff7422eb/17",
  "deckHref": "/decks/019de072-8046-72ee-8797-71c9ff7422eb",
  "deckJsonHref": "/decks/019de072-8046-72ee-8797-71c9ff7422eb.json",
  "deckAnchorHref": "/decks/019de072-8046-72ee-8797-71c9ff7422eb#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "paragraph",
      "text": "Clinical PoC demonstrated in US NAVY RECRUITS",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44a44f1a-7a9e-4563-9a45-9762d3354cf1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.03,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "4,712 subjects. 2 season, single site study had very few cases of HIL-214 vaccine strains of NoV. Clinical PoC demonstrated across any observed NoV strains due to heterotypic protection provided by HIL-214",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb95099e-f1bc-46bb-b31b-2ded3aa08266",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.1,
        "x": 0.35,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. GI.1 or GII.4",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f6bc22a-85e0-401b-a775-59248070ce29",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Sherwood et al, Vaccine 2020",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "51f71ddc-fdf9-4223-adfc-85601484614c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.6,
        "x": 0.35,
        "y": 0.25
      },
      "kind": "table",
      "text": "Pathogen, Placebo n=2357, HIL-214 n=2355, Viral efficacy %, p value. 1: HIL-214 vaccine strain only, 5 (0.2), 1 (<0.1), 80.0, p=0.142. 2: Any NoV strain, 26 (1.1), 10 (0.4), 61.8, p=0.0097. Post-hoc: GII.2 strain, 21, 9, 57.4, p=0.0321",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39ee0a45-7807-4085-8be6-cdeb1ac306ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.35,
        "y": 0.05
      },
      "kind": "title",
      "text": "Phase 2b demonstrated reduction in moderate-to-severe AGE",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83c6d307-a322-4cff-8155-601f6ae02a4c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 23,
      "from": 17,
      "beatId": "f4579335-9b5d-4c59-a7d9-e31f9a2392ff",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 17-23 outline the development plan, market opportunity, and anticipated milestones",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}